Bridger Management Sells Entire Stake in Bath & Body Works Amid Struggles
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy BBWI?
Source: Fool
- Share Sale Details: Bridger Management disclosed the sale of 300,619 shares of Bath & Body Works in Q4 2026, with an estimated transaction value of $7.74 million, indicating a strategic exit during a challenging market phase.
- Declining Company Performance: As of February 17, 2026, Bath & Body Works shares were priced at $24.67, down 32.3% year-over-year and underperforming the S&P 500 by 38.07 percentage points, highlighting its struggles in a competitive landscape.
- Fund Downsizing: Bridger Management's total assets under management (AUM) shrank by 16% quarter-over-quarter, reflecting a lack of confidence in market recovery, particularly given the poor performance during its holding period of Bath & Body Works.
- Uncertain Market Outlook: Despite a modest rebound in late 2025, Bath & Body Works faces ongoing challenges with stagnant sales and declining appeal among younger consumers, leading analysts to forecast lower sales in 2026, indicating significant long-term hurdles for the company.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBWI
Wall Street analysts forecast BBWI stock price to fall
14 Analyst Rating
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 22.520
Low
15.00
Averages
20.14
High
26.00
Current: 22.520
Low
15.00
Averages
20.14
High
26.00
About BBWI
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Bridger Management Sells Entire Stake in Bath & Body Works Amid Struggles
- Share Sale Details: Bridger Management disclosed the sale of 300,619 shares of Bath & Body Works in Q4 2026, with an estimated transaction value of $7.74 million, indicating a strategic exit during a challenging market phase.
- Declining Company Performance: As of February 17, 2026, Bath & Body Works shares were priced at $24.67, down 32.3% year-over-year and underperforming the S&P 500 by 38.07 percentage points, highlighting its struggles in a competitive landscape.
- Fund Downsizing: Bridger Management's total assets under management (AUM) shrank by 16% quarter-over-quarter, reflecting a lack of confidence in market recovery, particularly given the poor performance during its holding period of Bath & Body Works.
- Uncertain Market Outlook: Despite a modest rebound in late 2025, Bath & Body Works faces ongoing challenges with stagnant sales and declining appeal among younger consumers, leading analysts to forecast lower sales in 2026, indicating significant long-term hurdles for the company.
See More
Bridger Management Exits BBWI Stake Amid Market Challenges
- Share Sale Details: Bridger Management disclosed to the SEC on February 17, 2026, that it sold 300,619 shares of Bath & Body Works, with an estimated trade value of $7.74 million, reflecting strategic decisions amid market volatility.
- Asset Management Shift: This transaction resulted in a 4.98% change in Bridger's 13F reportable AUM, indicating that the fund no longer holds any shares post-trade, which suggests a lack of confidence in the company's future performance.
- Market Environment Challenges: Bath & Body Works has faced stagnating sales and declining popularity among Gen Z consumers in recent years, and despite a slight rebound in stock price at the end of 2025, Bridger's exit indicates a cautious outlook on future growth.
- Investor Advisory: Following Bridger's exit, analysts advise caution for investors considering Bath & Body Works stock, as the company did not make it onto Motley Fool's list of top 10 stocks, reflecting broader market concerns about its future performance.
See More
Bath & Body Works Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm's Advantage: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating a strong track record, urging investors to select experienced legal counsel.
- Investor Action Advice: Investors can visit Rosen Law Firm's website or call the toll-free number for more information on how to join the class action, ensuring they choose appropriate legal representation to protect their rights before the class is certified.
See More
Multiple Companies Face Class Action Lawsuits
- CoreWeave Lawsuit: CoreWeave, Inc. (NASDAQ:CRWV) is facing a class action lawsuit for failing to disclose its true ability to meet customer demand during the period from March 28 to December 15, 2025, with a lead plaintiff deadline of March 13, 2026, which could significantly impact the company's revenue.
- Bath & Body Works Lawsuit: Bath & Body Works, Inc. (NYSE:BBWI) is accused in a class action lawsuit covering June 4, 2024, to November 19, 2025, of not accurately reflecting the failure of its strategy involving
See More
Bath & Body Works Investors Class Action Reminder
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per diluted share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36, indicating significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company experienced a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, highlighting increasing pressure in a competitive market.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, opting to exit certain adjacencies and refocus on core categories to improve performance and restore growth potential.
- Legal Action: Investors have filed a class action lawsuit alleging that the company made misleading statements throughout the class period, failing to disclose adverse information, which could lead to significant losses for investors, with a deadline to file by March 16, 2026.
See More
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. faces a class action lawsuit for alleged violations of federal securities laws, targeting investors who purchased the company's securities between June 4, 2024, and November 19, 2025, seeking to recover damages for affected parties.
- False Statement Allegations: The complaint alleges that executives made materially false and misleading statements during this period, failing to disclose significant adverse facts about the company's business, operations, and prospects, which misled investors regarding its financial health.
- Strategic Failures: The lawsuit highlights that the company's strategy of pursuing 'adjacencies, collaborations, and promotions' did not effectively grow the customer base, and reliance on brand collaborations to mask weak financial results exacerbated the risk of investor losses.
- Investor Action Recommendations: Affected investors are encouraged to apply to be lead plaintiffs by March 13, 2026, and the law firm offers its services on a contingency fee basis, reducing the financial burden on investors seeking justice.
See More
Bridger Management Sells Entire Stake in Bath & Body Works Amid Struggles
- Share Sale Details: Bridger Management disclosed the sale of 300,619 shares of Bath & Body Works in Q4 2026, with an estimated transaction value of $7.74 million, indicating a strategic exit during a challenging market phase.
- Declining Company Performance: As of February 17, 2026, Bath & Body Works shares were priced at $24.67, down 32.3% year-over-year and underperforming the S&P 500 by 38.07 percentage points, highlighting its struggles in a competitive landscape.
- Fund Downsizing: Bridger Management's total assets under management (AUM) shrank by 16% quarter-over-quarter, reflecting a lack of confidence in market recovery, particularly given the poor performance during its holding period of Bath & Body Works.
- Uncertain Market Outlook: Despite a modest rebound in late 2025, Bath & Body Works faces ongoing challenges with stagnant sales and declining appeal among younger consumers, leading analysts to forecast lower sales in 2026, indicating significant long-term hurdles for the company.
See More
Bridger Management Exits BBWI Stake Amid Market Challenges
- Share Sale Details: Bridger Management disclosed to the SEC on February 17, 2026, that it sold 300,619 shares of Bath & Body Works, with an estimated trade value of $7.74 million, reflecting strategic decisions amid market volatility.
- Asset Management Shift: This transaction resulted in a 4.98% change in Bridger's 13F reportable AUM, indicating that the fund no longer holds any shares post-trade, which suggests a lack of confidence in the company's future performance.
- Market Environment Challenges: Bath & Body Works has faced stagnating sales and declining popularity among Gen Z consumers in recent years, and despite a slight rebound in stock price at the end of 2025, Bridger's exit indicates a cautious outlook on future growth.
- Investor Advisory: Following Bridger's exit, analysts advise caution for investors considering Bath & Body Works stock, as the company did not make it onto Motley Fool's list of top 10 stocks, reflecting broader market concerns about its future performance.
See More
Bath & Body Works Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm's Advantage: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating a strong track record, urging investors to select experienced legal counsel.
- Investor Action Advice: Investors can visit Rosen Law Firm's website or call the toll-free number for more information on how to join the class action, ensuring they choose appropriate legal representation to protect their rights before the class is certified.
See More
Multiple Companies Face Class Action Lawsuits
- CoreWeave Lawsuit: CoreWeave, Inc. (NASDAQ:CRWV) is facing a class action lawsuit for failing to disclose its true ability to meet customer demand during the period from March 28 to December 15, 2025, with a lead plaintiff deadline of March 13, 2026, which could significantly impact the company's revenue.
- Bath & Body Works Lawsuit: Bath & Body Works, Inc. (NYSE:BBWI) is accused in a class action lawsuit covering June 4, 2024, to November 19, 2025, of not accurately reflecting the failure of its strategy involving
See More
Bath & Body Works Investors Class Action Reminder
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per diluted share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36, indicating significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company experienced a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, highlighting increasing pressure in a competitive market.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, opting to exit certain adjacencies and refocus on core categories to improve performance and restore growth potential.
- Legal Action: Investors have filed a class action lawsuit alleging that the company made misleading statements throughout the class period, failing to disclose adverse information, which could lead to significant losses for investors, with a deadline to file by March 16, 2026.
See More
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. faces a class action lawsuit for alleged violations of federal securities laws, targeting investors who purchased the company's securities between June 4, 2024, and November 19, 2025, seeking to recover damages for affected parties.
- False Statement Allegations: The complaint alleges that executives made materially false and misleading statements during this period, failing to disclose significant adverse facts about the company's business, operations, and prospects, which misled investors regarding its financial health.
- Strategic Failures: The lawsuit highlights that the company's strategy of pursuing 'adjacencies, collaborations, and promotions' did not effectively grow the customer base, and reliance on brand collaborations to mask weak financial results exacerbated the risk of investor losses.
- Investor Action Recommendations: Affected investors are encouraged to apply to be lead plaintiffs by March 13, 2026, and the law firm offers its services on a contingency fee basis, reducing the financial burden on investors seeking justice.
See More
